IP Library Granted Patent US 8,212,016
Granted Patent B2
US 8,212,016 · App. 13/026,763 · Granted Jul 3, 2012

NPC1L1 orthologues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,212,016
App. No.
13/026,763
Granted
Jul 3, 2012
Kind
B2
Abstract

The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e.g., in screening assays, are also set forth.

Claims (8)

1. An isolated polynucleotide comprising a nucleotide sequence which is at least 95% identical to the nucleotide sequence set forth in SEQ ID NO: 7.

2. The isolated polynucleotide of claim 1 encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 8.

3. An isolated polynucleotide of claim 2 comprising the nucleotide sequence set forth in SEQ ID NO: 7.

4. A recombinant vector comprising the polynucleotide of claim 1 .

5. An isolated host cell comprising the vector of claim 4 .

6. A method for making a polypeptide comprising culturing the host cell of claim 5 under conditions in which the polynucleotide is expressed.

7. The method of claim 6 wherein the polypeptide is isolated from the culture.

8. The method of claim 6 wherein the host cell is a bacterial cell, an insect cell or a mammalian cell.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →